DD
David Drutz
Director

David Drutz insider trades: Altimmune (ALT) stock buys and sales

Director, Altimmune Last trade Aug 19, 2024 38 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2012
3
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 19, 2024ALT↓ Sell$111K
Aug 15, 2023ALT↑ Buy$863
Mar 23, 2023ALT↑ Buy$38K
Jun 15, 2022ALT↑ Buy$8K
May 24, 2022ALT↑ Buy$5K
Aug 23, 2017ALT↑ Buy$22K
May 17, 2013DARA↑ Buy$17K
Sep 17, 2012DARA↑ Buy$27K
Jun 8, 2012DARA↑ Buy$19K
May 29, 2012DARA↑ Buy$23K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ALT insiders

Open-market trades in the last 12 months

About David Drutz's insider trades

David Drutz is a director at Altimmune (ALT). Since May 29, 2012, David has reported 9 open-market purchases worth $161K and 1 sale worth $111K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (20 filings), option exercises (7 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.